Gemina Laboratories Ltd. (TSE:GLAB) has released an update.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Gemina Laboratories Ltd. has successfully raised $435,000 through the exercise of common share purchase warrants and has also settled a $40,000 debt with lenders by issuing 100,000 common shares at a discounted price. The company is known for its innovative biosensor and diagnostic technology, which is currently being developed for rapid testing of various pathogens, including COVID-19 and influenza.
For further insights into TSE:GLAB stock, check out TipRanks’ Stock Analysis page.